Skip to content
← Catalog

Inside Precision Medicine · 2026-03-27 · in vivo CAR-T toxicities review

Industry press coverage of ESO-T01 phase 1 in vivo BCMA CAR-T trial · references both Nature Medicine 2026 (PMID 41882404) and Lancet 2025 (DOI 10.1016/S0140-6736(25)01030-X)。 Frames the ESO-T01 data as serious-toxicity-in-all-patients narrative · is a primary anchor reference f…

Type
paper
Domain
oncology
Grade
conference
License
LIGHT_HOPE_proprietary
Provenance
m622_intel_seed_2026-05-16
evidence_grade
B
category
industry_press_review
status
verified
instance_tag
sunvax-antibody-2025
clinical_claim_softening
"industry press coverage · interpretive framing · primary data lies in cited Nature Medicine + Lancet papers"
journal
Inside Precision Medicine (industry press)
year
2026
authors
Jonathan D. Grinstein, PhD
abstract_snippet
Industry press coverage of ESO-T01 phase 1 in vivo BCMA CAR-T trial · references both Nature Medicine 2026 (PMID 41882404) and Lancet 2025 (DOI 10.1016/S0140-6736(25)01030-X)。 Frames the ESO-T01 data as serious-toxicity-in-all-patients narrative · is a primary anchor reference fo
View at source ↗

Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.